Exact Mass: 435.2039
Exact Mass Matches: 435.2039
Found 500 metabolites which its exact mass value is equals to given mass value 435.2039
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fosinoprilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Valsartan
Valsartan is an angiotensin-receptor blocker (ARB) that may be used to treat a variety of cardiac conditions including hypertension, diabetic nephropathy and heart failure. Valsartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Valsartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].
Cadabicine
Cadabicine is found in fruits. Cadabicine is an alkaloid from the stem bark of the famine food Cadaba farinosa (luquata sigmama). Alkaloid from the stem bark of the famine food Cadaba farinosa (luquata sigmama). Cadabicine is found in fruits.
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
Propranolol glucuronide
Trimazosin hydrochloride
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Melemeleone B
A sesquiterpenoid with a quinone and taurine functionality. It is isolated from the sponge Dysidea avara, and exhibits inhibitory activity against tyrosine kinase.
Phenol, 2,2,2-1H-indole-1,2,3-triyltris(methylene))tris-
(1RS,2RS,2aRS,10aSR)-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3H-cyclobuta[4,5]pyrano[3,2-c]quinolin-3-one|ARQ500206|euodenine A
Valsartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1075 CONFIDENCE standard compound; INTERNAL_ID 1112 CONFIDENCE standard compound; INTERNAL_ID 8608 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2583 INTERNAL_ID 1112; CONFIDENCE standard compound Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].
Ala Ala Phe Gln
Ala Ala Gln Phe
Ala Cys Asp Lys
Ala Cys Lys Asp
Ala Cys Arg Ser
Ala Cys Ser Arg
Ala Asp Cys Lys
Ala Asp Lys Cys
Ala Phe Ala Gln
Ala Phe Gln Ala
Ala Lys Cys Asp
Ala Lys Asp Cys
Ala Lys Met Ser
Ala Lys Ser Met
Ala Met Lys Ser
Ala Met Asn Thr
Ala Met Gln Ser
Ala Met Ser Lys
Ala Met Ser Gln
Ala Met Thr Asn
Ala Asn Met Thr
Ala Asn Thr Met
Ala Gln Ala Phe
Ala Gln Phe Ala
Ala Gln Met Ser
Ala Gln Ser Met
Ala Arg Cys Ser
Ala Arg Ser Cys
Ala Ser Cys Arg
Ala Ser Lys Met
Ala Ser Met Lys
Ala Ser Met Gln
Ala Ser Gln Met
Ala Ser Arg Cys
Ala Thr Met Asn
Ala Thr Asn Met
Cys Ala Asp Lys
Cys Ala Lys Asp
Cys Ala Arg Ser
Cys Ala Ser Arg
Cys Asp Ala Lys
Cys Asp Lys Ala
Cys Glu Gly Lys
Cys Glu Lys Gly
Cys Gly Glu Lys
Cys Gly Lys Glu
Cys Gly Arg Thr
Cys Gly Thr Arg
Cys Ile Asn Ser
Cys Ile Ser Asn
Cys Lys Ala Asp
Cys Lys Asp Ala
Cys Lys Glu Gly
Cys Lys Gly Glu
Cys Lys Ser Val
Cys Lys Val Ser
Cys Leu Asn Ser
Cys Leu Ser Asn
Cys Asn Ile Ser
Cys Asn Leu Ser
Cys Asn Ser Ile
Cys Asn Ser Leu
Cys Asn Thr Val
Cys Asn Val Thr
Cys Gln Ser Val
Cys Gln Val Ser
Cys Arg Ala Ser
Cys Arg Gly Thr
Cys Arg Ser Ala
Cys Arg Thr Gly
Cys Ser Ala Arg
Cys Ser Ile Asn
Cys Ser Lys Val
Cys Ser Leu Asn
Cys Ser Asn Ile
Cys Ser Asn Leu
Cys Ser Gln Val
Cys Ser Arg Ala
Cys Ser Val Lys
Cys Ser Val Gln
Cys Thr Gly Arg
Cys Thr Asn Val
Cys Thr Arg Gly
Cys Thr Val Asn
Cys Val Lys Ser
Cys Val Asn Thr
Cys Val Gln Ser
Cys Val Ser Lys
Cys Val Ser Gln
Cys Val Thr Asn
Asp Ala Cys Lys
Asp Ala Lys Cys
Asp Cys Ala Lys
Asp Cys Lys Ala
Asp Lys Ala Cys
Asp Lys Cys Ala
Asp Lys Ser Ser
Asp Ser Lys Ser
Asp Ser Ser Lys
Glu Cys Gly Lys
Glu Cys Lys Gly
Glu Gly Cys Lys
Glu Gly Lys Cys
Glu Lys Cys Gly
Glu Lys Gly Cys
Phe Ala Ala Gln
Phe Ala Gln Ala
Phe Gly Gly Arg
Phe Gly Asn Val
Phe Gly Arg Gly
Phe Gly Val Asn
Phe Asn Gly Val
Phe Asn Val Gly
Phe Gln Ala Ala
Phe Arg Gly Gly
Phe Val Gly Asn
Phe Val Asn Gly
Gly Cys Glu Lys
Gly Cys Lys Glu
Gly Cys Arg Thr
Gly Cys Thr Arg
Gly Glu Cys Lys
Gly Glu Lys Cys
Gly Phe Gly Arg
Gly Phe Asn Val
Gly Phe Arg Gly
Gly Phe Val Asn
Gly Gly Phe Arg
Gly Gly Arg Phe
Gly Lys Cys Glu
Gly Lys Glu Cys
Gly Lys Met Thr
Gly Lys Thr Met
Gly Met Lys Thr
Gly Met Gln Thr
Gly Met Thr Lys
Gly Met Thr Gln
Gly Asn Phe Val
Gly Asn Val Phe
Gly Gln Met Thr
Gly Gln Thr Met
Gly Arg Cys Thr
Gly Arg Phe Gly
Gly Arg Gly Phe
Gly Arg Thr Cys
Gly Thr Cys Arg
Gly Thr Lys Met
Gly Thr Met Lys
Gly Thr Met Gln
Gly Thr Gln Met
Gly Thr Arg Cys
Gly Val Phe Asn
Gly Val Asn Phe
Ile Cys Asn Ser
Ile Cys Ser Asn
Ile Asn Cys Ser
Ile Asn Ser Cys
Ile Ser Cys Asn
Ile Ser Asn Cys
Lys Ala Cys Asp
Lys Ala Asp Cys
Lys Ala Met Ser
Lys Ala Ser Met
Lys Cys Ala Asp
Lys Cys Asp Ala
Lys Cys Glu Gly
Lys Cys Gly Glu
Lys Cys Ser Val
Lys Cys Val Ser
Lys Asp Ala Cys
Lys Asp Cys Ala
Lys Asp Ser Ser
Lys Glu Cys Gly
Lys Glu Gly Cys
Lys Gly Cys Glu
Lys Gly Glu Cys
Lys Gly Met Thr
Lys Gly Thr Met
Lys Met Ala Ser
Lys Met Gly Thr
Lys Met Ser Ala
Lys Met Thr Gly
Lys Ser Ala Met
Lys Ser Cys Val
Lys Ser Asp Ser
Lys Ser Met Ala
Lys Ser Ser Asp
Lys Ser Val Cys
Lys Thr Gly Met
Lys Thr Met Gly
Lys Val Cys Ser
Lys Val Ser Cys
Leu Cys Asn Ser
Leu Cys Ser Asn
Leu Asn Cys Ser
Leu Asn Ser Cys
Leu Ser Cys Asn
Leu Ser Asn Cys
Met Ala Lys Ser
Met Ala Asn Thr
Met Ala Gln Ser
Met Ala Ser Lys
Met Ala Ser Gln
Met Ala Thr Asn
Met Gly Lys Thr
Met Gly Gln Thr
Met Gly Thr Lys
Met Gly Thr Gln
Met Lys Ala Ser
Met Lys Gly Thr
Met Lys Ser Ala
Met Lys Thr Gly
Met Asn Ala Thr
Met Asn Thr Ala
Met Gln Ala Ser
Met Gln Gly Thr
Met Gln Ser Ala
Met Gln Thr Gly
Met Ser Ala Lys
Met Ser Ala Gln
Met Ser Lys Ala
Met Ser Gln Ala
Met Thr Ala Asn
Met Thr Gly Lys
Met Thr Gly Gln
Met Thr Lys Gly
Met Thr Asn Ala
Met Thr Gln Gly
Asn Ala Met Thr
Asn Ala Thr Met
Asn Cys Ile Ser
Asn Cys Leu Ser
Asn Cys Ser Ile
Asn Cys Ser Leu
Asn Cys Thr Val
Asn Cys Val Thr
Asn Phe Gly Val
Asn Phe Val Gly
Asn Gly Phe Val
Asn Gly Val Phe
Asn Ile Cys Ser
Asn Ile Ser Cys
Asn Leu Cys Ser
Asn Leu Ser Cys
Asn Met Ala Thr
Asn Met Thr Ala
Asn Ser Cys Ile
Asn Ser Cys Leu
Asn Ser Ile Cys
Asn Ser Leu Cys
Asn Thr Ala Met
Asn Thr Cys Val
Asn Thr Met Ala
Asn Thr Thr Thr
Asn Thr Val Cys
Asn Val Cys Thr
Asn Val Phe Gly
Asn Val Gly Phe
Asn Val Thr Cys
Gln Ala Ala Phe
Gln Ala Phe Ala
Gln Ala Met Ser
Gln Ala Ser Met
Gln Cys Ser Val
Gln Cys Val Ser
Gln Phe Ala Ala
Gln Gly Met Thr
Gln Ser Thr Thr
Gln Thr Ser Thr
Gln Thr Thr Ser
Arg Ala Cys Ser
Arg Ala Ser Cys
Arg Cys Ala Ser
Arg Cys Gly Thr
Arg Cys Ser Ala
Arg Cys Thr Gly
Arg Phe Gly Gly
Arg Gly Cys Thr
Arg Gly Phe Gly
Arg Gly Gly Phe
Arg Gly Thr Cys
Arg Ser Ala Cys
Arg Ser Cys Ala
Arg Ser Ser Ser
Arg Thr Cys Gly
Arg Thr Gly Cys
Ser Ala Cys Arg
Ser Ala Lys Met
Ser Ala Met Lys
Ser Ala Arg Cys
Ser Cys Ala Arg
Ser Cys Lys Val
Ser Cys Arg Ala
Ser Cys Val Lys
Ser Asp Lys Ser
Ser Asp Ser Lys
Ser Lys Ala Met
Ser Lys Cys Val
Ser Lys Asp Ser
Ser Lys Met Ala
Ser Lys Ser Asp
Ser Lys Val Cys
Ser Met Ala Lys
Ser Met Lys Ala
Ser Gln Thr Thr
Ser Arg Ala Cys
Ser Arg Cys Ala
Ser Arg Ser Ser
Ser Ser Asp Lys
Ser Ser Lys Asp
Ser Ser Arg Ser
Ser Ser Ser Arg
Ser Thr Gln Thr
Ser Thr Thr Gln
Ser Val Cys Lys
Ser Val Lys Cys
Thr Cys Gly Arg
Thr Cys Arg Gly
Thr Gly Cys Arg
Thr Gly Lys Met
Thr Gly Met Lys
Thr Gly Arg Cys
Thr Lys Gly Met
Thr Lys Met Gly
Thr Met Gly Lys
Thr Met Lys Gly
Thr Asn Thr Thr
Thr Gln Ser Thr
Thr Gln Thr Ser
Thr Arg Cys Gly
Thr Arg Gly Cys
Thr Ser Gln Thr
Thr Ser Thr Gln
Thr Thr Asn Thr
Thr Thr Gln Ser
Thr Thr Ser Gln
Thr Thr Thr Asn
Val Cys Lys Ser
Val Cys Ser Lys
Val Phe Gly Asn
Val Phe Asn Gly
Val Gly Phe Asn
Val Gly Asn Phe
Val Lys Cys Ser
Val Lys Ser Cys
Val Asn Phe Gly
Val Asn Gly Phe
Val Ser Cys Lys
Val Ser Lys Cys
Cadabicine
nomega-(2-acetamido-2-deoxy-beta-d-glucopyranosyl)-nalpha-(tert-butoxycarbonyl)-l-asparagine
(3R,5S,E)-METHYL 7-(2-CYCLOPROPYL-4-(4-FLUOROPHENYL)QUINOLIN-3-YL)-3,5-DIHYDROXYHEPT-6-ENOATE
Thieno[2,3-b]quinoline-2-carboxamide, N-cyclopentyl-N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl- (9CI)
DANSYL-GAMMA-AMINO-N-BUTYRIC ACID CYCLOHEXYLAMMONIUM SALT
4-NITROPHENYL PHOSPHATE DI(CYCLOHEXYLAMINE) SALT MONOHYDRATE
4-Nitrophenyl phosphate,bis(cyclohexylammonium) salt hydrate
OPIPRAMOL DIHYDROCHLORIDE
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
(3R,4R)-N-Hydroxy-4-({4-[(2-methyl-4-quinolinyl)methoxy]benzoyl}a mino)tetrahydro-2H-pyran-3-carboxamide
2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
2,4-Diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
2-[1-[2-(diethylamino)-2-oxoethyl]-3-indolyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoacetamide
2-Acetoxy-1-acetyl-3,6-di(tert-butylthio)-4-phenyl-1,2,3,6-tetrahydropyridine
TRIMAZOSIN
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents